4 recruiting, 2 completed, 1 unknown, 1 withdrawn. 4 Not applicable, 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Recruiting 2, Unknown 1, Withdrawn 1 |
| Phase 1 | 3 | Recruiting 2, Completed 1 |
| Phase 2 | 3 | Recruiting 2, Completed 1 |
Follow Gastrointestinal Cancer Metastatic: new trials by email Literature Review of Gastrointestinal Cancer Metastatic trials Research Report on Gastrointestinal Cancer Metastatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma BHB810 - Gastric Cancer, Gastric Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | BigHat Biosciences, Inc. | 164 | 2026-07-16 | 2026-10-20 |
| Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers Electronic Patient Reported Outcomes platform, Health Related Quality of Life Surveys - Gastrointestinal Cancers, Gastrointestinal Cancer Metastatic | Not applicable | Withdrawn | University of California, San Francisco | 2024-06-15 | 2024-05-08 | |
| MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy Outcomes MRI/Spectroscopy - Gastrointestinal Cancer Metastatic | Not applicable | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 70 | 2021-12-15 | 2024-08-02 |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes PICO G2 4k - Cancer Pain, Visceral Pain | Not applicable | Recruiting | Cedars-Sinai Medical Center | 360 | 2021-10-05 | 2026-02-20 |
| A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer Bemarituzumab, Modified FOLFOX6 - Gastrointestinal Cancer, Gastrointestinal Cancer Metastatic | Phase 1 | Completed | Five Prime Therapeutics, Inc. | 12 | 2017-11-30 | 2024-02-28 |
| Drug Sensitivity Screening for Gastrointestinal Cancer Personalized drug sensitivity test - Gastrointestinal Cancer Metastatic | Not applicable | Unknown | Peking University Cancer Hospital & Institute | 40 | 2017-05-01 | 2020-03-06 |
| Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer Tirapazamine, Conventional Transarterial Embolization (TAE) - Hepatocellular Carcinoma, Gastrointestinal Cancer Metastatic | Phase 1 / Phase 2 | Recruiting | Teclison Ltd. | 25 | 2014-09-01 | 2026-04-20 |
| 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer 5-Fluorouracil and Interferon - Gastrointestinal Cancer Metastatic, Renal Cell Cancer Metastatic | Phase 2 | Completed | Western Regional Medical Center | 18 | 2012-07-01 | 2018-03-21 |
Gastrointestinal Neoplasms (5) · Stomach Neoplasms (3) · Colonic Neoplasms (2) · Neuroendocrine Tumors (2) · Pancreatic Neoplasms (2) · Adenocarcinoma (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Bile Duct Neoplasms (1) · Biliary Tract Neoplasms (1) · Cancer Pain (1) · Carcinoid Tumor (1) · Carcinoma, Hepatocellular (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1)
Digestive System Diseases (6) · Digestive System Neoplasms (6) · Neoplasms by Site (6) · Gastrointestinal Diseases (5) · Neoplasms (5) · Carcinoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Stomach Diseases (3) · Adenocarcinoma (2) · Colonic Diseases (2) · Colorectal Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Intestinal Diseases (2)
Ethiodized Oil (1) · Fluorouracil (1) · Interferons (1) · Magnetic Resonance Spectroscopy (1) · Quality of Life (1) · Tirapazamine (1) · bemarituzumab (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · BigHat Biosciences, Inc. (1) · Cedars-Sinai Medical Center (1) · Five Prime Therapeutics, Inc. (1) · Peking University Cancer Hospital & Institute (1) · Teclison Ltd. (1) · University of California, San Francisco (1) · Western Regional Medical Center (1)
United States (5) · China (1) · Netherlands (1)
Aiwen Wu, M.D. (1) · Brennan Spiegel, MD, MSHS (1) · Hanneke WM van Laarhoven, MD PhD (1) · Michael Soulen, MD (1) · Scott Irwin, MD, PhD (1) · Walter Quan, MD (1) · Wesley A Kidder, MD (1)
R01CA252211 (1)